Immune Therapeutics, Inc.
IMUN · OTC
12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
|---|---|---|---|---|
| Market Cap | $22 | $1 | $7 | $3 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $1 | $3 | $3 | $6 |
| Enterprise Value | $22 | $4 | $10 | $8 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$1 | $2 | -$1 | -$2 |
| % Margin | – | – | – | – |
| Net Income | -$6 | $4 | $1 | -$5 |
| % Margin | – | – | – | – |
| EPS Diluted | -0.16 | 0.38 | 2.4 | -10.44 |
| % Growth | -142.1% | -84.2% | 123% | – |
| Operating Cash Flow | -$1 | -$0 | -$0 | -$0 |
| Capital Expenditures | -$1 | $0 | $0 | $0 |
| Free Cash Flow | -$1 | -$0 | -$0 | -$0 |